Orion Biotech Opportunities Net Tangible Assets

Orion Biotech Opportunities (ORIA) currently reports a net tangible assets of $200M as of December 2022. That compares with $-14M in the prior-year period — up 1517.6% year over year. Use the charts on this page to explore Orion Biotech Opportunities's net tangible assets history and peer comparisons.

Orion Biotech Opportunities's net tangible assets increased from $-14M to $200M — a 1517.6% year-over-year increase (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Orion Biotech Opportunities reported $200M in net tangible assets as of December 2022. That compares with $-14M in the prior-year period — up 1517.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $200M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Orion Biotech Opportunities, and consider following ORIA for alerts when major investors trade the stock.